Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Elisabeth Hazard"'
Autor:
David Klingman, Michael C. Reed, Julie Munakata, Marcia F.T. Rupnow, Jonothan C. Tierce, Richard B. Lipton, Elisabeth Hazard, Daniel Serrano
Publikováno v:
Headache: The Journal of Head and Face Pain. 49:498-508
Objective.— To evaluate the impact of incident transformed migraine on health care resource utilization, medication use, and productivity loss. In addition, the study estimates the total direct and indirect costs associated with transformed migrain
Publikováno v:
Clinical therapeutics. 31(4)
Background: Tumor necrosis factor (TNF) antagonists are commonly used to treat rheumatoid arthritis (RA). Differences in the dosage and mode of administration of these agents may result in differential rates of dosage adjustment and costs of care. Ob
Autor:
Wilbert S. Aronow, Michael A. Blazing, Sidney C. Smith, E. Magnus Ohman, Robert S. Rosenson, Karen P. Alexander, Elisabeth Hazard
Publikováno v:
Journal of cardiovascular pharmacology and therapeutics. 14(1)
Cardiovascular disease is the leading cause of death in men and women older than 65 years; therefore, its prevention is an important public health priority. Although cardiovascular risk is multifactorial, elevated low-density lipoprotein cholesterol
Autor:
Elisabeth, Hazard, Spencer B, Cherry, Deepa, Lalla, J Michael, Woolley, Helen, Wilfehrt, Chiun-Fang, Chiou
Publikováno v:
Managed care interface. 19(4)
In an effort to assess the burden associated with psoriasis, the MEDLINE database and bibliographies of articles published from 1975 through 2004 were searched, emphasizing patients with moderate-to-severe disease, to summarize the current understand
Publikováno v:
BMC Health Services Research
BMC Health Services Research, Vol 11, Iss 1, p 101 (2011)
BMC Health Services Research, Vol 11, Iss 1, p 101 (2011)
Background Controlled trials have found therapeutic plasma exchange (TPE) and intravenous immunoglobulin (IVIg) infusion therapy to be equally efficacious in treating Guillain-Barré syndrome (GBS). Due to increases in the price of IVIg compared to h